REGENXBIO, Inc. (RGNX)

9.49 +0.30 (+3.26%) USD  |  NASDAQ  |  Apr 17, 16:00
9.51 +0.02 (+0.21%) Pre-Market: 20:00
More

REGENXBIO Total Operating Expenses (% of Quarterly Revenues)

Total Operating Expenses (% of Quarterly Revenues) Chart

View Total Operating Expenses (% of Quarterly Revenues) for RGNX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Operating Expenses (% of Quarterly Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Operating Expenses (% of Quarterly Revenues) Range, Past 5 Years

View Total Operating Expenses (% of Quarterly Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Operating Expenses (% of Quarterly Revenues) Benchmarks

View Total Operating Expenses (% of Quarterly Revenues) Benchmarks
Start Trial
Sarepta Therapeutics, Inc. Upgrade
AbbVie, Inc. Upgrade
Replimune Group, Inc. --
Ocugen, Inc. Upgrade
Krystal Biotech, Inc. Upgrade